ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,996Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 617

$559K Total Retail Price of All Prescriptions

Rank: 66 out of 617

404 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 404 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,633 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 487 409 1 2
LEVOTHYROXINE SODIUM 465 385 2 1
FUROSEMIDE 383 324 3 4
OMEPRAZOLE 379 354 4 3
LISINOPRIL 340 300 5 5
CITALOPRAM HBR 271 213 6 18
AMLODIPINE BESYLATE 259 251 7 6
POTASSIUM CHLORIDE 248 230 8 10
HYDROCHLOROTHIAZIDE 225 215 9 13
METOPROLOL TARTRATE 216 193 10 11
ATORVASTATIN CALCIUM 200 173 11 14
PRAVASTATIN SODIUM 188 183 12 21
HYDROCODONE-ACETAMINOPHEN 187 167 S3 13 8
WARFARIN SODIUM 183 159 14 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 182 173 15 29
METFORMIN HCL 175 136 16 9
METOPROLOL SUCCINATE 172 137 17 12
ATENOLOL 165 153 18 17
DONEPEZIL HCL 164 163 19 30
GABAPENTIN 146 127 20 16
SERTRALINE HCL 137 131 21 20
RANITIDINE HCL 135 108 22 40
NAMENDA 135 135 22 35
LOVASTATIN 129 113 24 57
PANTOPRAZOLE SODIUM 125 124 25 37
TRAMADOL HCL 122 115 26 15
CARVEDILOL 119 119 27 19
MIRTAZAPINE 115 109 28 50
RISPERIDONE 110 103 29 71
SPIRONOLACTONE 106 94 30 42
POLYETHYLENE GLYCOL 3350 105 105 31 32
ALLOPURINOL 97 71 32 27
BENAZEPRIL HCL 94 91 33 44
CRESTOR 88 78 34 28
LOSARTAN POTASSIUM 87 84 35 22
SPIRIVA 87 81 35 61
CYMBALTA 87 74 35 49
CARBIDOPA-LEVODOPA 83 83 38 69
IPRATROPIUM-ALBUTEROL 83 79 38 151
PREDNISONE 79 61 40 31
ALENDRONATE SODIUM 75 70 41 25
MORPHINE SULFATE ER 73 73 S2 42 128
ADVAIR DISKUS 72 71 43 38
ROPINIROLE HCL 71 71 44 66
QUETIAPINE FUMARATE 71 71 44 78
ZOLPIDEM TARTRATE 69 45 46 23
FLUTICASONE PROPIONATE 67 67 47 36
ISOSORBIDE MONONITRATE ER 67 67 47 52
MELOXICAM 66 53 49 24
TRIAMCINOLONE ACETONIDE 66 64 49 102
SYNTHROID 64 64 51 59
VERAPAMIL ER 64 50 51 90
LANTUS 64 59 51 39
FORTICAL 56 56 54 302
DIGOXIN 56 56 54 48
GLIPIZIDE 54 37 56 82
TRIAMTERENE-HCTZ 53 41 57 47
KLOR-CON M20 52 46 58 116
GLIMEPIRIDE 51 49 59 33
JANUVIA 50 50 60 107
PROAIR HFA 50 44 60 75
DETROL LA 50 46 60 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 27, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.